News
Blackstone closes record $6.3bn life sciences fund
Blackstone has closed its latest fund – the $6.3bn BXLS VI – saying it is the largest ever private fund for the life sciences sector.
News
Amgen's BiTE for lung cancer backed for EU approval
Amgen's fast-growing bispecific T-cell engager Imdylltra should be cleared as a second-line therapy for small cell lung cancer, said the CHMP.
News
AI predicts liver cancer risk with "high accuracy"
A machine learning algorithm could serve as a pre-screen for hepatocellular carcinoma that identifies patients missed by current narrow guidance.
News
Corcept gets FDA OK for first-in-class ovarian cancer drug
Corcept shares surge on FDA approval of Lifyorli, a first-in-class selective glucocorticoid receptor antagonist for ovarian cancer.
News
Update: Rumour confirmed as MSD buys Terns for $6.7bn
MSD's glut of pipeline-boosting deals in the build-up to a looming patent cliff has continued with a $6.7bn bid to acquire Terns Pharma.
News
Views & Analysis
Deep Dive
Editor's Picks
Editor's Picks
